Ecs Botanics Holdings Ltd · ASX:ECS
Ecs Botanics — Merger or Acquisition (February 2021)
11 slides from Ecs Botanics's merger presentation, Feb 3, 2021
Slide 1: Acquisition of Murray Meds
For personal use only Acquisition of Murray Meds| February 2021 1 1
Slide 2: Corporate Snapshot and Capital Structure (Post Acquisition of Murray Meds)
CAPITAL STRUCTURE (POST ACQUISITION OF MURRAY MEDS) For personal use only CORPORATE SNAPSHOT Share on • ECS to acquire Victoria-based Murray Meds, a fully issue 774.88m licensed and permitted cannabis cultivator with TGA Good Manufacturing Practice (GMP) manufacture Performance licence for dried flo
Slide 3: Board of Directors – Murray Meds founder to join Board
BOARD OF DIRECTORS – Murray Meds founder to join Board BOARD OF DIRECTORS PROPOSED DIRECTOR For personal use only Alexander Keach David McCredie OBE Nan-Maree Schoerie Managing Director Non-Executive Chairman Executive Director Prior to founding Murray Meds, Nan-Maree held the Australian business le
Slide 4: Why ECS Botanics?
WHY ECS BOTANICS? For personal use only Scale and Diversity Financial Strength - • Largest ASX listed THC and CBD cultivator in Australia • Fixed assets including Property valued at $6.0m • Food, wellness & medicine • No debt • Geographical spread reduces risk • Low Cost, Asset and Overheads light m
Slide 5: What Murray Meds Brings to ECS
WHAT MURRAY MEDS BRINGS TO ECS For personal use only Speed to market Climate advantage One of the most advanced companies in Australia High THC medicinal cannabis likes a hot dry climate for the cultivation of medicinal cannabis. All permits with high DLI and low humidity. and licenses obtained in r
Slide 6: Murray Meds in Action
MURRAY MEDS IN ACTION For personal use only 170 acre farm – 7 acres for cannabis cultivation – located on Murray River with water rights to 520ML/pa 6 6
Slide 7: Complementary to ECS Medicinal Cannabis Facility – Tasmania
COMPLEMENTARY TO ECS MEDICINAL CANNABIS FACILITY – TASMANIA For personal use only • Medicinal cannabis facility nearing competition for phase 1 – fit out and installation underway • Equipment technology transfer & medicinal cannabis offtake term sheet signed with MediPharm Labs • Additional discussi
Slide 8: Medicinal Cannabis Process Flow
MEDICINAL CANNABIS PROCESS FLOW Current & Near Term Production Process For personal use only OILS 3rd PARTY EXTRACTION, RESIN FOLLOWED BY IN-HOUSE EXTRACTION (TASMANIA) Ethanol Medium Term Production Process Extraction Secure storage OILS IN-HOUSE RESIN EXTRACTION & ISOLATES Despatch ISOLATES Cultiv
Slide 9: Medicinal Cannabis Sales
MEDICINAL CANNABIS SALES For personal use only • Strong qualified sales pipeline leveraging disruptive pricing model targeting markets in Australia, UK and Europe Supply agreements for: • White Label THC oils to EU and UK Term Sheet Medipharm Labs • Cannabis Clinics Supply Agreement to provide resin
Slide 10: Peer Comparison
PEER COMPARISON The landscape in Australia is diverse for cannabis and hemp-related companies. While there is a wide field of For personal use only participants, few compete directly or have a strategy similar to ECS. Company Code/valuation Comments ASX:LGP • FY2020 Revenue $2.2m and $9.3m loss Litt
Slide 11: Contact us
For personal use only Contact us Alexander Keach Managing Director alex@ecsbotanics.com.au +61 419 323 059 ecsbotanics.com.au @ecsbotanics 11 11
ECS Botanics Holdings — Merger or Acquisition (February 2021) on 6ix